Long-Term Doxycycline Therapy for Stable Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Drawbacks?
- PMID: 37734069
- PMCID: PMC10867923
- DOI: 10.1164/rccm.202307-1301LE
Long-Term Doxycycline Therapy for Stable Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Drawbacks?
Comment in
- 
  
  Reply to Martinez-Garcia et al. and to Wang et al.Am J Respir Crit Care Med. 2023 Nov 15;208(10):1144-1145. doi: 10.1164/rccm.202309-1604LE. Am J Respir Crit Care Med. 2023. PMID: 37734070 Free PMC article. No abstract available.
Comment on
- 
  
  A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2023 Sep 1;208(5):549-558. doi: 10.1164/rccm.202212-2287OC. Am J Respir Crit Care Med. 2023. PMID: 37450935 Free PMC article. Clinical Trial.
References
- 
    - Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP, Vestbo J, Feenstra TL. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J . 2011;37:508–515. - PubMed
 
- 
    - Zafari Z, Li S, Eakin MN, Bellanger M, Reed RM. Projecting long-term health and economic burden of COPD in the United States. Chest . 2021;159:1400–1410. - PubMed
 
- 
    - Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med . 2017;195:557–582. - PubMed
 
- 
    - Prins HJ, Daniels JMA, Lindeman JH, Lutter R, Boersma WG. Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial. Respir Med . 2016;110:46–52. - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
        